Journal of cancer research and clinical oncology
-
J. Cancer Res. Clin. Oncol. · Oct 2013
Review Meta AnalysisThe efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
The incidence of hot flashes under hormone manipulation therapy is so high that this symptom caused by sex hormone blocking agents has been bothering patients and has a negative impact on their quality of life. Venlafaxine and gabapentin are most promising novel nonestrogenic agents to control the symptom. We seek to quatitatively summarize the efficacy of these novel agents. ⋯ Venlafaxine/gabapentin significantly improved hot flashes in cancer patients under hormone manipulation therapies.